Quinoxalines

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 360 Experts worldwide ranked by ideXlab platform

Akhilesh K Verma - One of the best experts on this subject based on the ideXlab platform.

Kasi V Sankar - One of the best experts on this subject based on the ideXlab platform.

Anxin Wu - One of the best experts on this subject based on the ideXlab platform.

Mahendra Nath - One of the best experts on this subject based on the ideXlab platform.

Nalilu Suchetha Kumari - One of the best experts on this subject based on the ideXlab platform.

  • synthesis of some new 4 styryltetrazolo 1 5 a quinoxaline and 1 substituted 4 styryl 1 2 4 triazolo 4 3 a quinoxaline derivatives as potent anticonvulsants
    European Journal of Medicinal Chemistry, 2009
    Co-Authors: Shivananda Wagle, Airody Vasudeva Adhikari, Nalilu Suchetha Kumari
    Abstract:

    4-Methyltetrazolo[1,5-a]quinoxaline (3) was prepared by the azide cyclocondensation of 2-chloro-3-methylquinoxaline (2). The reaction of 3 with aromatic aldehydes furnished 4-styryltetrazolo[1,5-a]Quinoxalines (4a-f). Compound 2, on treatment with hydrazine hydrate gave 2-hydrazino-3-methylquinoxaline (5). The ring closure of 5 was achieved by the reaction of orthoesters and trifluoroacetic acid to yield 4-methyl-1-(substituted)[1,2,4]triazolo[4,3-a]Quinoxalines (7a-c). Further, reaction of 7a-c with different aromatic aldehydes furnished the title compounds, 4-styryl-1-(substituted)[1,2,4]triazolo[4,3-a]Quinoxalines (8a-i) in good yield. In another scheme, the hydrazino compound 5 was treated with different aromatic aldehydes to yield corresponding N-arylidenehydrazino Quinoxalines (6a-d). Further, the oxidative cyclization of hydrazones by nitrobenzene yielded 1-aryl-4-methyl[1,2,4]triazolo[4,3-a]Quinoxalines (7d-g), which on condensation with aromatic aldehydes gave the title compounds, 1-aryl-4-styryl[1,2,4]triazolo[4,3-a]Quinoxalines (8j-u). The newly synthesized compounds have been characterized by FTIR, (1)H NMR, (13)C NMR and mass spectral data, followed by elemental analysis. Some of the compounds were screened for in vivo anticonvulsant activity. Few of them exhibited promising results.